Results 181 to 190 of about 55,141 (338)

A Nationwide Danish Comparative Effectiveness Study of GLP‐1 RA, SGLT2i and DPP‐4i Treatment on Risk of Stroke, Myocardial Infarction and Mortality in Type 2 Diabetes

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
New users of GLP‐1 RA in type 2 diabetes had a lower risk of stroke and new users of GLP‐1 RA and SGLT2i in type 2 diabetes had a lower risk of mortality in comparison with new users of DPP‐4i in routine clinical settings. There were no differences in myocardial infarction.
Sidsel Hastrup   +5 more
wiley   +1 more source

Target analysis and identification of curcumin against vascular calcification

open access: yesScientific Reports
To investigate the mechanism of curcumin (CUR) on vascular calcification (VC), we screen for common targets of CUR and atherosclerosis and verify the targets genes in vivo and in vitro experiments.
Qingjie Li   +8 more
doaj   +1 more source

Biflavonoids can Potentially Inhibit Amyloid Beta Internalization to Mitigate Its Cytotoxic Events

open access: yesMolecular Nutrition &Food Research, Volume 70, Issue 2, 29 January 2026.
Biflavonoids attenuate amyloid‐β (Aβ) induced cellular toxicity by inhibiting Aβ entry into cells. This blockade suppresses apoptosis‐related pathways, including caspase activation and nuclear lamin fragmentation, thereby promoting cellular protection and neuroprotective effects.
Md. Aminul Haque   +3 more
wiley   +1 more source

Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications [PDF]

open access: gold, 2019
Yannick Chantran   +3 more
openalex   +1 more source

Response to – Counteracting white matter injury to mitigate APOE4‐related ARIA

open access: yes
Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Zahra Shirzadi, Jasmeer P. Chhatwal
wiley   +1 more source

Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo   +3 more
wiley   +1 more source

Early Detection of Central Nervous System Involvement in ATTRv Using Multimodal MRI and Cognitive Assessments

open access: yesEuropean Journal of Neurology, Volume 33, Issue 1, January 2026.
Multimodal MRI uncovers early signs of central nervous system damage in patients with ATTRv, including asymptomatic carriers. White matter structural changes detected through DTI represent a highly sensitive early biomarker of central impairment, likely linked to TTR amyloid angiopathy.
Renan Flávio de França Nunes   +4 more
wiley   +1 more source

Corrigendum: Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease

open access: yesFrontiers in Neurology, 2021
Brandon M. Fox   +3 more
doaj   +1 more source

Unveiling the Proteomic Landscape of Extracellular Vesicles: Implications for Neurodegeneration and Neuroprotection

open access: yesJournal of Neurochemistry, Volume 170, Issue 1, January 2026.
Extracellular vesicles (EVs) are tiny, membrane‐covered packets that cells naturally release to send molecular information to one another. In the brain, they function as couriers that move proteins, lipids, and other signals between neurons, glial cells, and the blood–brain barrier.
Berenice N. Bernal‐Vicente   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy